Ordinary Rebalance | Solactive China Biotech Innovation Index | Effective Date 13th November 2023
In the ordinary rebalance, the following composition will be implemented effective open 13.11.2023:
| 3SBIO INC |
| ALPHAMAB ONCOLOGY |
| ANHUI HUAHENG BIOTECHNOLOGY CO LTD |
| ASCENTAGE PHARMA GROUP INTERNATIONAL |
| BEIJING BOHUI INNOVATION B-A |
| BEIJING SCITOP BIO-TECH CO-A |
| BEIJING SL PHARMACEUTICAL -A |
| BEIJING TIANTAN BIOLOGICAL-A |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD |
| BGI GENOMICS CO LTD-A |
| CANSINO BIOLOGICS INC |
| CHANGCHUN BCHT BIOTECHNOLOGY CO |
| CHANGCHUN HIGH & NEW TECH-A |
| CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD |
| CHENGDU OLYMVAX BIOPHARMAC-A |
| CHINA ANIMAL HUSBANDRY-A |
| CHONGQING ZHIFEI BIOLOGICA-A |
| CSPC PHARMACEUTICAL GROUP LTD |
| DAAN GENE CO LTD-A |
| FRONTIER BIOTECHNOLOGIES I-A |
| GENSCRIPT BIOTECH CORP |
| GETEIN BIOTECH INC-A |
| GUANGZHOU WONDFO BIOTECH C-A |
| HEBEI CHANGSHAN BIOCHEMICA-A |
| HITGEN INC-A |
| HUALAN BIOLOGICAL BACTERIN INC |
| HUALAN BIOLOGICAL ENGINEER-A |
| JACOBIO PHARMACEUTICALS GROUP CO LTD |
| JOINN LABORATORIES CHINA CO LTD |
| LIAONING CHENGDA BIOTECHNOLOGY |
| MABWELL SHANGHAI BIOSCIENCE CO LTD |
| NANJING VAZYME BIOTECH CO LTD |
| PACIFIC SHUANGLIN BIO-PHARMACY |
| SHANGHAI RAAS BLOOD PRODUC-A |
| SHANGHAI ZJ BIO-TECH CO LT-A |
| SHENZHEN KANGTAI BIOLOGICA-A |
| SHENZHEN WEIGUANG BIOLOGIC-A |
| SICHUAN KELUN PHARMACEUTIC-A |
| WALVAX BIOTECHNOLOGY CO-A |
| WUHAN KEQIAN BIOLOGY CO LT-A |
| WUXI BIOLOGICS CAYMAN INC |
| XIAMEN AMOYTOP BIOTECH CO -A |
| ZAI LAB LTD |
| ZHEJIANG SHENGHUA BIOK BIOLOGY CO. LTD. CLASS A |